ATE256147T1 - Peptide gegen pilzen - Google Patents

Peptide gegen pilzen

Info

Publication number
ATE256147T1
ATE256147T1 AT95928105T AT95928105T ATE256147T1 AT E256147 T1 ATE256147 T1 AT E256147T1 AT 95928105 T AT95928105 T AT 95928105T AT 95928105 T AT95928105 T AT 95928105T AT E256147 T1 ATE256147 T1 AT E256147T1
Authority
AT
Austria
Prior art keywords
peptides
amino acids
against fungi
peptides against
wlqlf
Prior art date
Application number
AT95928105T
Other languages
English (en)
Inventor
Roger G Ii Little
Edward Lim
Mitchell B Fadem
Original Assignee
Xoma Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/306,473 external-priority patent/US5652332A/en
Priority claimed from US08/372,105 external-priority patent/US5627153A/en
Application filed by Xoma Technology Ltd filed Critical Xoma Technology Ltd
Application granted granted Critical
Publication of ATE256147T1 publication Critical patent/ATE256147T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4742—Bactericidal/Permeability-increasing protein [BPI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT95928105T 1994-09-15 1995-07-20 Peptide gegen pilzen ATE256147T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/306,473 US5652332A (en) 1993-03-12 1994-09-15 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
US08/372,105 US5627153A (en) 1994-01-14 1995-01-13 Anti-fungal methods and materials
PCT/US1995/009262 WO1996008509A1 (en) 1994-09-15 1995-07-20 Anti-fungal peptides

Publications (1)

Publication Number Publication Date
ATE256147T1 true ATE256147T1 (de) 2003-12-15

Family

ID=26975179

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95928105T ATE256147T1 (de) 1994-09-15 1995-07-20 Peptide gegen pilzen

Country Status (7)

Country Link
EP (1) EP0824547B1 (de)
JP (1) JPH10508576A (de)
AT (1) ATE256147T1 (de)
AU (1) AU709738B2 (de)
CA (1) CA2200069C (de)
DE (1) DE69532302D1 (de)
WO (1) WO1996008509A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652332A (en) * 1993-03-12 1997-07-29 Xoma Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
JP2001520631A (ja) * 1995-07-20 2001-10-30 ゾーマ コーポレイション 抗真菌性ペプチド
US5741779A (en) * 1996-05-10 1998-04-21 Xoma Corporation Antithrombotic materials and methods
DK0914144T3 (da) 1996-05-10 2001-04-09 Univ Texas Terapeutiske anvendelser af BPI-protein-produkter til human meningokokæmi
AU736096B2 (en) * 1996-05-23 2001-07-26 Xoma Corporation Therapeutic uses of BPI protein products in humans with hemorrhage due to trauma
US5888973A (en) * 1996-08-09 1999-03-30 Xoma Corporation Anti-chlamydial uses of BPI protein products
US6482796B2 (en) 1996-11-01 2002-11-19 Xoma Corporation Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients
US6093573A (en) * 1997-06-20 2000-07-25 Xoma Three-dimensional structure of bactericidal/permeability-increasing protein (BPI)
US6013631A (en) * 1998-06-19 2000-01-11 Xoma Corporation Bactericidal/permeability-increasing protein (BPI) deletion analogs
WO2000018798A1 (en) * 1998-09-25 2000-04-06 Xoma Technology Ltd. Antifungal and antibacterial peptide
US6242219B1 (en) 1999-03-18 2001-06-05 Xoma (Us) Llc Methods for recombinant peptide production
US6355616B1 (en) 1999-06-25 2002-03-12 Xoma (Us) Technology Ltd. Derivative compounds derived from or based on bactericidal/permeability-increasing protein
US7192737B2 (en) 2002-03-29 2007-03-20 Xoma Technology Ltd. Methods and materials for increasing expression of recombinant polypeptides
GB201319621D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Antimicrobial agents and their use in therapy
GB201319620D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Immunosuppressive agents and their use in therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733872A (en) * 1993-03-12 1998-03-31 Xoma Corporation Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
AU694108B2 (en) * 1993-03-12 1998-07-16 Xoma Corporation Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
MX9401807A (es) * 1993-03-12 1995-01-31 Xoma Corp Usos terapeuticos de productos de proteina que incrementan lapermeabilidad/bactericidas.
MX9602570A (es) * 1994-01-14 1997-04-30 Xoma Corp Metodos y materiales anti-fungosos.

Also Published As

Publication number Publication date
AU709738B2 (en) 1999-09-02
CA2200069C (en) 2000-09-26
AU3198195A (en) 1996-03-29
EP0824547B1 (de) 2003-12-10
DE69532302D1 (de) 2004-01-22
EP0824547A1 (de) 1998-02-25
JPH10508576A (ja) 1998-08-25
CA2200069A1 (en) 1996-03-21
WO1996008509A1 (en) 1996-03-21

Similar Documents

Publication Publication Date Title
ATE256147T1 (de) Peptide gegen pilzen
ES2563677T3 (es) Composiciones de combinaciones de Neisseria
ATE368053T1 (de) Antimikrobielle peptide
AU4162400A (en) Derivatives of the b or z domain from staphylococcal protein a (spa) interactingwith at least one domain of human factor viii
NO20100324L (no) Fremgangsmate for trinnvis festing av polyetylenglykol (PEG) andeler i serie til et polypeptid
NZ263344A (en) Human bactericidal/permeability increasing (bpi) protein functional domain peptides and their use
DE69526216D1 (de) Antifungaleverfahren und mitteln
ATE213500T1 (de) Antifungizide peptide auf der grundlage von d- aminosäuren enthaltendem histatin
DE69535948D1 (de) Von wd-40 abstammende peptide und ihre verwendung
ATE196475T1 (de) Auf histatin basierende, gegen pilze und bakterien gerichtete peptide
DE60035419D1 (de) Antigene peptide aus neisseria
DE69629075D1 (de) Zyklische Peptide mit fungizider Wirkung
ATE280777T1 (de) Bradykinin-antagonist peptide mit n- substituierten glycinen
FI970579A0 (fi) Andenovirus, joka käsittää glutationiperoksidaasia koodittavan geenin
CA2249180A1 (en) Methods for recombinant microbial production of bpi-fusion proteins and bpi-derived peptides
ATE175119T1 (de) Vakzine gegen immunodefizienz-virus der katze (kiv)
DE69624167D1 (de) Zyklische Peptide mit fungizider Wirkung
ATE193022T1 (de) Heparin-und sulfatid-bindende peptide vom typ 1 der wiederkehrenden sequenzen vom menschlichen thrombospondin
DE69840024D1 (de) Antimikrobielle Peptide, abstammend von Ubiquicidin
ATE412745T1 (de) Antiangiogene peptide vom n-terminus von endostatin
ATE435870T1 (de) Aus ll-37 abgeleiteten peptidinhibitoren von toxinen
NO20040880L (no) Casein avledete peptider og anvendelser derav i terapi.
DE69935599D1 (de) Modifizierte hcv peptid-impfstoffe
DE69932834D1 (de) Chi-Conotoxinpeptide als Inhibitoren neuronaler Amintransporter
NO20005081D0 (no) Et polypeptid inneholdende aminosyren fra et N-terminalt kolinbindende protein A-truncat, vaksine avledet derfra og anvendelser derav

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties